PR Newswire Asia's news > Biotechnology

 < Previous page   |   Detail   |   Print    Next page > 
     
KOLON TISSUEGENE HIGHLIGHTS LONG-TERM SAFETY DATA AND POTENTIAL U.S. FDA PATHWAY FOR TG-C AT OARSI WORLD CONGRESS
2025-04-28T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Complete Genomics, Velsera partner to integrate sequencing and analysis platforms
2025-04-28T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
Kangpu Biopharmaceuticals Received CDE Approval for Phase IIb Clinical Trial of KPG-818 in Moderate to Severe Cutaneous Manifestations of SLE
2025-04-28T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Celltrion to present six abstracts in inflammatory bowel disease (IBD) at 2025 Digestive Disease Week® (DDW)
2025-04-28T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
WuXi AppTec Q1 2025 Revenue, Profit Resume Double Digit Growth, Revenue Up 21.0% YoY, Adjusted Non-IFRS Net Profit Up 40.0% YoY; Backlog for Continuing Operations Up 47.1% YoY
2025-04-28T    Banking/Financial Service   Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Comac Medical Announces New Leadership Appointments and International Expansion
2025-04-28T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
YolTech Announces First Clinical Data from Ongoing Investigator-Initiated Trial of YOLT-101, An In-Vivo Base Editing Therapy for Familial Hypercholesterolemia
2025-04-28T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
2025 AACR | Abbisko Therapeutics Presents Late-Breaking Pre-clinical Research Results on ABSK112 (EGFR exon20ins), ABSK131 (PRMT5*MTA), and ABK-KRAS-1
2025-04-28T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
ImmVira Presented Clinical Results of Oncolytic Product MVR-C5252 Targeting Malignant Glioma via Convection-Enhanced Delivery at 2025 AACR Annual Meeting
2025-04-28T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
Nona Biosciences' Partner Pfizer Presents Preclinical Data on TOP1i-Based ADC Targeting MSLN at AACR Annual Meeting 2025
2025-04-28T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
 < Previous page    Next page >

 

88iv | Home |  Login
Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer
Copyright (C) 2025
Suntek Computer Systems Limited.
All rights reserved